IL263683B - Microbial carotenoids affecting the microbial composition in the gut - Google Patents

Microbial carotenoids affecting the microbial composition in the gut

Info

Publication number
IL263683B
IL263683B IL263683A IL26368318A IL263683B IL 263683 B IL263683 B IL 263683B IL 263683 A IL263683 A IL 263683A IL 26368318 A IL26368318 A IL 26368318A IL 263683 B IL263683 B IL 263683B
Authority
IL
Israel
Prior art keywords
microbial
carotenoids
composition
affecting
affecting gut
Prior art date
Application number
IL263683A
Other languages
English (en)
Hebrew (he)
Other versions
IL263683A (en
Inventor
Sam Possemiers
Cindy Duysburgh
Iris Pinheiro
Selin Bolca
Den Abbeele Pieter Van
Massimo Marzorati
Original Assignee
Prodigest Bvba
Microbial Res Management Health Nv
Sam Possemiers
Cindy Duysburgh
Iris Pinheiro
Selin Bolca
Den Abbeele Pieter Van
Massimo Marzorati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodigest Bvba, Microbial Res Management Health Nv, Sam Possemiers, Cindy Duysburgh, Iris Pinheiro, Selin Bolca, Den Abbeele Pieter Van, Massimo Marzorati filed Critical Prodigest Bvba
Publication of IL263683A publication Critical patent/IL263683A/en
Publication of IL263683B publication Critical patent/IL263683B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL263683A 2016-06-22 2018-12-12 Microbial carotenoids affecting the microbial composition in the gut IL263683B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (2)

Publication Number Publication Date
IL263683A IL263683A (en) 2019-01-31
IL263683B true IL263683B (en) 2022-04-01

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
IL263683A IL263683B (en) 2016-06-22 2018-12-12 Microbial carotenoids affecting the microbial composition in the gut

Country Status (12)

Country Link
US (1) US11324717B2 (cg-RX-API-DMAC7.html)
EP (1) EP3474862B1 (cg-RX-API-DMAC7.html)
JP (1) JP6966543B2 (cg-RX-API-DMAC7.html)
KR (1) KR102413408B1 (cg-RX-API-DMAC7.html)
CN (1) CN109641006B (cg-RX-API-DMAC7.html)
AU (1) AU2017281589B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018076485A8 (cg-RX-API-DMAC7.html)
CA (1) CA3028031C (cg-RX-API-DMAC7.html)
IL (1) IL263683B (cg-RX-API-DMAC7.html)
MX (1) MX390386B (cg-RX-API-DMAC7.html)
RU (1) RU2759600C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017220708A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10220089B2 (en) 2012-08-29 2019-03-05 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
AU2015339284B2 (en) 2014-10-30 2021-08-05 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
WO2018148220A1 (en) * 2017-02-07 2018-08-16 California Institute Of Technology Modulation of gut microbiota in huntington's disease and rett syndrome
EP3720458A4 (en) 2017-12-05 2021-12-08 BioPlx, Inc. METHODS AND COMPOSITIONS FOR PREVENTING MICROBIAL INFECTION
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
GB0524873D0 (en) * 2005-12-06 2006-01-11 New Royal Holloway & Bedford Bacterial production of carotenoids
GB201013041D0 (en) * 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids

Also Published As

Publication number Publication date
RU2019101481A (ru) 2020-07-22
CA3028031C (en) 2023-02-28
AU2017281589B2 (en) 2023-03-23
US20190209516A1 (en) 2019-07-11
KR102413408B1 (ko) 2022-06-27
CA3028031A1 (en) 2017-12-28
BR112018076485A2 (pt) 2019-04-09
IL263683A (en) 2019-01-31
EP3474862B1 (en) 2025-10-29
BR112018076485A8 (pt) 2022-12-06
JP6966543B2 (ja) 2021-11-17
KR20190039687A (ko) 2019-04-15
CN109641006B (zh) 2022-07-01
RU2019101481A3 (cg-RX-API-DMAC7.html) 2020-10-16
MX390386B (es) 2025-03-20
RU2759600C2 (ru) 2021-11-16
CN109641006A (zh) 2019-04-16
US11324717B2 (en) 2022-05-10
JP2019524877A (ja) 2019-09-05
AU2017281589A1 (en) 2019-01-31
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
EP3474862A1 (en) 2019-05-01

Similar Documents

Publication Publication Date Title
ZA202002723B (en) Composition
GB2533527B (en) Anti-microbial composition
IL263683B (en) Microbial carotenoids affecting the microbial composition in the gut
GB201703455D0 (en) Composition
SG11201911697WA (en) Microbial compositions
GB201707238D0 (en) Composition
GB2562466B (en) Composition
GB201614087D0 (en) Anti-microbial composition
GB201719139D0 (en) Composition
GB201700504D0 (en) Composition
DK3573468T3 (en) Fat Composition
GB201713636D0 (en) Composition
PL3675653T3 (pl) Kompozycja przeciwmykotoksynowa
GB201712151D0 (en) Composition
GB201702833D0 (en) Composition
LT3576546T (lt) Probiotikų kompozicija
GB201721674D0 (en) Composition
GB201718871D0 (en) Composition
GB201711446D0 (en) Composition
GB201709905D0 (en) Composition
GB201707920D0 (en) Composition
ZA201904385B (en) Composition
GB201816988D0 (en) Composition
DK3582624T3 (en) Fat composition
GB201715135D0 (en) Composition